Affiliation:
1. Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research; Shanghai Institute of Materia Medica, Chinese Academy of Sciences; Shanghai People's Republic of China
2. University of Chinese Academy of Sciences; Beijing People's Republic of China
Funder
“Personalized Medicines-Molecular Signature-based Drug Discovery and Development”, Strategic Priority Research Program of the Chinese Academy of Sciences, Chinese Academy of Sciences
National Science and Technology Major Project “Key New Drug Creation and Manufacturing Program”, Ministry of Science and Technology of the People's Republic of China
the Fudan-SIMM Joint Research Fund
National Natural Science Foundation of China
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献